Oxidative stress after kidney transplantation: The role of immunosuppression

Dialysis and Transplantation

Volumn 39, Issue 9, 2010, Pages 391-394

  Štrebl, Pavel ^a   Horčička Jr , Vladko ^a   Krejčí, Karel ^a   Horák, Pavel ^a   Vostálová, Jitka ^b   Zdařilová, Adéla ^b   Kajabová, Markéta ^a   Schneiderka, Petr ^a   Zadražil, Josef ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ALBUMIN; C REACTIVE PROTEIN; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UREA;

ADULT; ARTICLE; BLOOD CELL COUNT; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEMATOLOGICAL PARAMETERS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; OXIDATIVE STRESS; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

EID: 77957359091     PISSN: 00902934     EISSN: 19326920     Source Type: Journal    
DOI: 10.1002/dat.20484     Document Type: Article

References (16)

1. Simic-Ogrizovic S, Simic T, Reljic Z, et al. Markers of oxidative stress after renal transplantation. Transpl Int. 1998;11:125-129. (Pubitemid 128683524)
2. Thomas SR, Neuzil J, Mohr D, et al. Coantioxidants make alpha-tocopherol an efficient antioxidant for low density lipoprotein. Am J Clin Nutr. 1995;62:1357S-1364S.
3. Vural A, Yilmaz MI, Caglar K, et al. Assessment of oxidative stress in the early posttransplant period: comparison of cyclosporine A and tacrolimus-based regiment. Am J Nephrol. 2005;25:250-255. (Pubitemid 41202747)
4. Capeillere-Blandin C, Delevau T, Descamps-Latscha B. Structural modifications of human ;β2 microglobulin treated with oxygen-derived radicals. Biochem J. 1991;277:175-182.
5. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304-1313. (Pubitemid 26166404)
6. Annuk M. Which marker is informative in characterizing the level of oxidative stress in ESRD patients? Nephron Clin Pract. 2004;98:c1-2.
7. Campise M, Bamonti F, Novembrino C, et al. Oxidative stress in kidney transplant patients. Transplantation. 2003;76:1474-1478.
8. De Cal M, Silva S, Cruz D, et al. Oxidative stress and 'monocyte reprogramming' after kidney transplant: a longitudinal study. Blood Purif. 2008;26:105-110.
9. Antolini F, Valente F, Ricciardi D, et al. Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients. Clin Chim Acta. 2005;358:87-94. (Pubitemid 40966636)
10. Fingerova H, Novotny J, Barborik J, et al. Antioxidant capacity of seminal plasma measured by TAS Randox. Biomed Pap Med Fac Univ Palacky Olomouc Czech Republic. 2007;151:37-40.
11. Varghese Z, Fernando RL, Turakhia G, et al. Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients. Kidney Int. 1999;71:137-140. (Pubitemid 29304834)
12. Varghese Z, Fernando RL, Turakhia G, et al. Oxidizability of low-density lipoproteins from neoral and tacrolimus-treated renal transplant patients. Transplant Proc. 1998;30:2043-2046.
13. Watschinger B, Sayegh MH. Endothelin in organ transplantation. Am J Kidney Dis. 1996;27:151-156.
14. Pirsch JD, Miller J, Deierhoi MH, et al. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation. 1997;63:977-983.
15. Andoh TF, Burdmann EA, Bennett WM. Nephrotoxicity of immunosuppressive drugs. Experimental and clinical observations. Semin Nephrol. 1997;17:34-35.
16. Perrea DN, Moulakakis KG, Poulakou MV, et al. Correlation between oxidative stress and immunosuppressive therapy in renal transplant recipients with an uneventful postoperative course and stable renal function. Int Urol Nephrol. 2006;38:343-348.